We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 261-280 of 302 results
  1. Muzinöse Neoplasien der Appendix vermiformis, Pseudomyxoma peritonei und die neue WHO-Klassifikation

    Mucinous neoplasms of the appendix are rare tumors, some of them characterized by an enigmatic discrepancy between a benign morphologic appearance...

    S. Reu, J. Neumann, T. Kirchner in Der Pathologe
    Article 18 December 2011
  2. Gastrointestinal

    Article 01 February 2013
  3. Gastrointestinal

    Article 30 January 2013
  4. An Asian perspective on organ transplantation

    The organ transplantation seems to have become a route practice of modern medical treatment when a patient's organ fails providing that she/he can...

    Michael Cheng-tek Tai in Wiener Medizinische Wochenschrift
    Article 01 September 2009
  5. Abstract

    Article 30 July 2010
  6. Gastrointestinal

    Article 01 January 2009
  7. Gastrointestinal

    Article 01 January 2009
  8. Pseudomyxoma Peritonei: Clinical Pathological and Biological Prognostic Factors in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

    Background

    Surgical cytoreduction combined with hyperthermic intraperitoneal chemotherapy (HIPEC) has been recently advocated as the standard of care...

    Dario Baratti, Shigeki Kusamura, ... Marcello Deraco in Annals of Surgical Oncology
    Article 28 November 2007
  9. Gastrointestinal

    Article 01 February 2007
  10. Gastrointestinal

    Article 01 February 2007
  11. A Systematic Review on the Efficacy of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei

    Background

    The efficacy of cytoreductive surgery (CRS) combined with perioperative intraperitoneal chemotherapy (PIC) for patients with pseudomyxoma...

    Tristan D. Yan, Deborah Black, ... Paul H. Sugarbaker in Annals of Surgical Oncology
    Article 12 October 2006
  12. AURKA is one of the downstream targets of MAPK1/ERK2 in pancreatic cancer

    DUSP6/MKP-3, a specific inhibitor of MAPK1/ERK2, frequently loses its expression in primary pancreatic cancer tissues. This evidence suggests that...

    T Furukawa, N Kanai, ... A Horii in Oncogene
    Article 13 March 2006
Did you find what you were looking for? Share feedback.